measuregroup/AID1803209

Predicate	Object
has specified output	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID340132362_AID1803209_PMID_VALUE5 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID136351904_AID1803209_PMID_VALUE1 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID340132363_AID1803209_PMID_VALUE6 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID340132361_AID1803209_PMID_VALUE4 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID340132363_AID1803209_PMID_VALUE7 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID340129260_AID1803209_PMID_VALUE3 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID340129259_AID1803209_PMID_VALUE2
has participant	http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP47746 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP34972
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/BindingDB
title	Competition Receptor Binding Assay from US Patent US9416103: \"Use of the aminoalkylindole JWH-073-M4 and related compounds as neutral CB1 receptor antagonists for the treatment of alcoholism, drug abuse, obesity, and obesity-related diseases\"
type	http://www.bioassayontology.org/bao#BAO_0000040

Predicate	Subject
participates in	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID340129259 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID340132363 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID340132362 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136351904 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID340132361 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID340129260
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID1803209

Total number of triples: 19.